The clinical drug candidate anle138b binds predominantly to a central cavity in lipidic Ab40 fibrils and modulates fibril formation. - Han, Mookyoung; Frieg, Benedikt; Matthes, Dirk; Leonov, Andrei; Ryazanov, Sergey; Giller, Karin; Nimerovsky, Evgeny; Stampolaki, Marianna; Xue, Kai; Overkamp, Kerstin; Dienemann, Christian; Riedel, Dietmar; et al. (Biological Magnetic Resonance Bank, 2025)